Emily Collier, MDAssistant Professor AdjunctCardsAdditional TitlesHeme-Onc Medicine Fellow, Medical OncologyLearn moreabout Additional TitlesContact Infoemily.collier@yale.eduLearn moreabout Contact InfoAboutResearchNewsGet In TouchEmily CollierAboutCopy LinkTitlesAssistant Professor AdjunctHeme-Onc Medicine Fellow, Medical OncologyAppointmentsMedical Oncology and HematologyAssistant Professor AdjunctPrimaryOther Departments & OrganizationsCenter for Thoracic CancersInternal MedicineMedical OncologyMedical Oncology and HematologyYale Cancer CenterEducation & TrainingInternal Medicine ResidentBrigham and Women's Hospital (2012)MDHarvard Medical School, Harvard-MIT Health Sciences and Technology Program (2009)BSYale University School of Medicine, Molecular Cellular and Developmental Biology (2002)ResearchCopy LinkClinical TrialsCurrent TrialsRandomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)HIC ID2000032879RoleSub InvestigatorPrimary Completion Date12/31/2026Recruiting ParticipantsLung CancerLUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)HIC ID2000025282RoleSub InvestigatorPrimary Completion Date01/28/2029Recruiting ParticipantsLung CancerNewsCopy LinkNewsFebruary 24, 2021Releasing the Brakes on an Innate Immune System ResponseRead moreabout Releasing the Brakes on an Innate Immune System ResponseGet In TouchCopy LinkContactsEmailemily.collier@yale.edu
Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)HIC ID2000032879RoleSub InvestigatorPrimary Completion Date12/31/2026Recruiting ParticipantsLung Cancer
LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)HIC ID2000025282RoleSub InvestigatorPrimary Completion Date01/28/2029Recruiting ParticipantsLung Cancer
February 24, 2021Releasing the Brakes on an Innate Immune System ResponseRead moreabout Releasing the Brakes on an Innate Immune System Response